Copyright Reports & Markets. All rights reserved.

Global Anti–vascular Endothelial Growth Factor Therapy Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Extraction Injection
    • 1.2.3 Precharge Injection
  • 1.3 Market by Application
    • 1.3.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Macular Degeneration
    • 1.3.3 Nacular Edema
    • 1.3.4 Uveitis
    • 1.3.5 Retinal Vein Occlusion
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Perspective (2016-2027)
  • 2.2 Anti–vascular Endothelial Growth Factor Therapy Growth Trends by Regions
    • 2.2.1 Anti–vascular Endothelial Growth Factor Therapy Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Anti–vascular Endothelial Growth Factor Therapy Historic Market Share by Regions (2016-2021)
    • 2.2.3 Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Regions (2022-2027)
  • 2.3 Anti–vascular Endothelial Growth Factor Therapy Industry Dynamic
    • 2.3.1 Anti–vascular Endothelial Growth Factor Therapy Market Trends
    • 2.3.2 Anti–vascular Endothelial Growth Factor Therapy Market Drivers
    • 2.3.3 Anti–vascular Endothelial Growth Factor Therapy Market Challenges
    • 2.3.4 Anti–vascular Endothelial Growth Factor Therapy Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Anti–vascular Endothelial Growth Factor Therapy Players by Revenue
    • 3.1.1 Global Top Anti–vascular Endothelial Growth Factor Therapy Players by Revenue (2016-2021)
    • 3.1.2 Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Players (2016-2021)
  • 3.2 Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Anti–vascular Endothelial Growth Factor Therapy Revenue
  • 3.4 Global Anti–vascular Endothelial Growth Factor Therapy Market Concentration Ratio
    • 3.4.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Anti–vascular Endothelial Growth Factor Therapy Revenue in 2020
  • 3.5 Anti–vascular Endothelial Growth Factor Therapy Key Players Head office and Area Served
  • 3.6 Key Players Anti–vascular Endothelial Growth Factor Therapy Product Solution and Service
  • 3.7 Date of Enter into Anti–vascular Endothelial Growth Factor Therapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Anti–vascular Endothelial Growth Factor Therapy Breakdown Data by Type

  • 4.1 Global Anti–vascular Endothelial Growth Factor Therapy Historic Market Size by Type (2016-2021)
  • 4.2 Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Type (2022-2027)

5 Anti–vascular Endothelial Growth Factor Therapy Breakdown Data by Application

  • 5.1 Global Anti–vascular Endothelial Growth Factor Therapy Historic Market Size by Application (2016-2021)
  • 5.2 Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Anti–vascular Endothelial Growth Factor Therapy Market Size (2016-2027)
  • 6.2 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
    • 6.2.1 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021)
    • 6.2.2 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2022-2027)
    • 6.2.3 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2027)
  • 6.3 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
    • 6.3.1 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021)
    • 6.3.2 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2022-2027)
    • 6.3.3 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2027)
  • 6.4 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country
    • 6.4.1 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2016-2021)
    • 6.4.2 North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size (2016-2027)
  • 7.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
    • 7.2.1 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021)
    • 7.2.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2022-2027)
    • 7.2.3 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2027)
  • 7.3 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
    • 7.3.1 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021)
    • 7.3.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2022-2027)
    • 7.3.3 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2027)
  • 7.4 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country
    • 7.4.1 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2016-2021)
    • 7.4.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size (2016-2027)
  • 8.2 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
    • 8.2.1 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
    • 8.3.1 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region
    • 8.4.1 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size (2016-2027)
  • 9.2 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
    • 9.2.1 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021)
    • 9.2.2 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2022-2027)
    • 9.2.3 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2027)
  • 9.3 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
    • 9.3.1 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021)
    • 9.3.2 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2022-2027)
    • 9.3.3 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2027)
  • 9.4 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country
    • 9.4.1 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2016-2021)
    • 9.4.2 Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size (2016-2027)
  • 10.2 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
    • 10.2.1 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
    • 10.3.1 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country
    • 10.4.1 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Regeneron Pharmaceuticals (Eylea)
    • 11.1.1 Regeneron Pharmaceuticals (Eylea) Company Details
    • 11.1.2 Regeneron Pharmaceuticals (Eylea) Business Overview
    • 11.1.3 Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Introduction
    • 11.1.4 Regeneron Pharmaceuticals (Eylea) Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2016-2021)
    • 11.1.5 Regeneron Pharmaceuticals (Eylea) Recent Development
  • 11.2 Genentech
    • 11.2.1 Genentech Company Details
    • 11.2.2 Genentech Business Overview
    • 11.2.3 Genentech Anti–vascular Endothelial Growth Factor Therapy Introduction
    • 11.2.4 Genentech Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2016-2021)
    • 11.2.5 Genentech Recent Development
  • 11.3 Kanghong Pharmaceutical
    • 11.3.1 Kanghong Pharmaceutical Company Details
    • 11.3.2 Kanghong Pharmaceutical Business Overview
    • 11.3.3 Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Introduction
    • 11.3.4 Kanghong Pharmaceutical Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2016-2021)
    • 11.3.5 Kanghong Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Anti–vascular Endothelial Growth Factor Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti–vascular Endothelial Growth Factor Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Extraction Injection
    Precharge Injection

    Segment by Application
    Macular Degeneration
    Nacular Edema
    Uveitis
    Retinal Vein Occlusion

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Regeneron Pharmaceuticals (Eylea)
    Genentech

    Buy now